ALGN Medical Devices · Dental tech · Clear aligners · Global healthcare · Thesis updated August 5, 2026

Activist pressure meets stabilizing aligner prices

In Q2 2026, Clear Aligner revenue grew 8.2% to $870.9 million, making up 82% of total revenue.
Case volume rose 7.4%, and average selling price increased 0.8% to $1,260 per case.
Systems and Services revenue dropped 10.8% to $185.3 million due to a shift toward scanner leases.
Activist investor Elliott Management sparked a strategic review and a new stock buyback plan.
A new 20% U.K. tax ruling creates a headwind for European sales starting in September 2026.

01 Running thesis

Pricing holds as activists step in

Align's core story took a sharp turn in the summer of 2026. Activist investor Elliott Management is now involved, pushing the company to start a comprehensive strategic review and expand share repurchases. At the same time, Q2 2026 proved that the previous quarter's pricing stability was not a fluke. Clear Aligner volume rose 7.4% and the average selling price held steady at $1,260.

The bull case focuses on this solid foundation. If Invisalign pricing remains stable, the company can grow margins without sacrificing volume. The shift to leasing iTero scanners hurts upfront revenue but successfully expanded the active scanner base by 11%. More scanners in dental offices means more future Invisalign cases.

The bear case points to structural weakness in the equipment market. Systems and Services revenue fell 10.8% year over year. While management blames the shift to leasing, dentists are clearly cautious about buying expensive equipment outright. A new 20% value-added tax in the U.K. will also make clear aligners more expensive for a key European market starting in September.

Finn's view is that the activist involvement provides a strong floor for the stock. However, growth will remain lumpy until the U.K. tax impact is understood and the scanner leasing strategy proves it can generate sustainable recurring revenue.

Jul 2026▲Activist investor Elliott Management got involved, sparking a strategic review. Q2 results showed stable aligner pricing, though scanner revenue dropped due to a shift toward leasing.

May 2026▲Q1 2026 showed the first real challenge to the 2025 bear case. Clear Aligner revenue rose 7.4%, case volume rose 6.7%, and revenue per case rose 0.8% to $1,250.

Feb 2026→The 2025 Form 10-K confirmed the main tension. Clear Aligner volume rose 4.7% for the year, but average selling price fell 3.9% and operating margin compressed to 13.5% after restructuring and other charges.

Nov 2025→Q3 2025 shifted the concern from demand to profit. Clear Aligner revenue grew 2.4% on 4.9% case growth, but ASP fell 2.4% and gross margin was hurt by restructuring and impairment charges.

Aug 2025▼Q2 2025 reinforced the bear case. Clear Aligner revenue fell 3.3% as revenue per case dropped 3.5% to $1,250, mostly from mix and discounts.

May 2025▼Q1 2025 was a sharp negative data point. Clear Aligner ASP fell 8.1%, offsetting 6.2% case volume growth, while Systems and Services slowed to 1.2% growth.

Feb 2025→The 2024 Form 10-K showed a split business. Systems and Services grew 16.0%, but Clear Aligner revenue in the Americas fell 2.5% and ASP pressure remained clear.

Nov 2024→Q3 2024 kept the same debate alive. Systems and Services grew 15.6%, but Clear Aligner revenue fell 1.0% and the Americas were down 4.7%.

02 Business model

Selling cases, leasing scanners

Align makes most of its money by selling Invisalign treatment packages directly to orthodontists and general dentists. The dentist buys the case from Align, then treats the patient. Align also sells retainers, training, and other non-case products tied to clear aligner treatment.

The second business provides iTero intraoral scanners and exocad software used by dental labs. A scanner replaces a messy physical mold with a digital scan of the mouth. Historically, Align sold these machines upfront. Now, the company is shifting to leasing and rental programs. This lowers immediate revenue but makes it cheaper for dentists to adopt the technology.

The model works best when the two parts feed each other. A dentist who leases an iTero scanner is more likely to send Invisalign cases to Align. That creates a sticky digital system.

Where it breaks is price pressure. Clear aligners face heavy competition. If dentists or patients push for cheaper options, Align has to offer discounts. That hurts revenue per case and squeezes margins.

03 Product portfolio

The dental stack

Cash cow

Invisalign system

This is Align's main product line. It includes clear aligner treatment packages such as Comprehensive, Moderate, Lite, Express, and First.

Steady

Vivera retainers

Vivera retainers help patients keep their teeth in place after treatment. They add repeat revenue tied to the Invisalign base.

Growth engine

iTero scanners

iTero scanners take digital 3D scans of the mouth. The company is actively pushing lease and rental models to grow the installed base.

Steady

Align and iTero software

Tools like Align Oral Health Suite and iTero Design Suite help dentists plan, show, and manage care.

Option

exocad CAD/CAM software

exocad serves dental labs and supports digital design and manufacturing workflows. It gives Align a wider role in dental work beyond clear aligners.

Option

Cubicure direct 3D printing

Align bought Cubicure in 2024 for proprietary direct 3D printing technology. The goal is to eventually make devices without first creating molds.

04 Business segments

Still an Invisalign company

Clear Aligner82%modest

Systems and Services18%declining

Segment mix is from Q2 2026 revenue. Clear Aligner makes up about 82% of revenue, meaning volume and pricing in Invisalign still dictate company performance.

05 Risk factors

What could break the recovery

New U.K. tax burden

Medium impact · High odds

A U.K. tribunal ruled that clear aligners are not exempt from value-added taxes. Starting September 2026, a 20% tax will be added to U.K. invoices. This will make Invisalign much more expensive for patients and could crush volume in a key market.

We watchPatient volume and case growth in the U.K. and Europe in late 2026.

Scanner revenue decline

Medium impact · High odds

Systems and Services revenue fell nearly 11% in Q2 2026. The company is pushing dentists to lease scanners instead of buying them. If those leased scanners do not translate into higher Invisalign case volumes, Align simply traded high upfront cash for a weak rental stream.

We watchThe conversion rate of leased iTero scanners into new Invisalign cases.

ASP slide returns

High impact · Medium odds

Average selling price stabilized in early 2026, hitting $1,260 per case. If discounts, cheaper product mix, or currency issues push ASP down again, volume growth will not turn into better profits.

We watchClear Aligner revenue per case across the back half of 2026.

Consumer spending pressure

Medium impact · Medium odds

Clear aligners are often a large out-of-pocket purchase for families. When consumers feel squeezed by inflation or job fears, they delay treatment. That can hurt case volume even if dentists still prefer the product.

We watchTeen case growth, total case volume, and management comments on patient conversion.

Geopolitical and manufacturing shocks

Medium impact · Medium odds

Align has iTero operations headquartered in Israel and manufacturing exposure in Mexico. A supply disruption could hurt scanner supply, aligner production, or raise freight costs.

We watchAny filing updates on Israel operations, Mexico manufacturing, or supply chain delays.

06 Quick answers

In one breath

How does Align Technology make money?

Align mainly sells Invisalign clear aligner cases to orthodontists and dentists. It also sells or leases iTero scanners, scanner software, disposables, retainers, and dental lab software.

Why does average selling price matter so much for ALGN?

Average selling price shows how much Align earns per clear aligner case. In 2025, volume grew while price fell, which hurt margins. In 2026, price finally stabilized, lifting profits.

Why is activist investor Elliott Management involved?

Elliott Management stepped in to push for better commercial execution and capital allocation. This led to a strategic review of the operating model and a larger share buyback plan.

What should investors watch next?

Watch the outcome of the strategic review, Clear Aligner ASP, and U.K. case volume after the new 20% tax takes effect in September 2026.